RE/MAX Holdings, Inc.
NYSE:RMAXReal Estate - Services
+$0.30 today
- Market cap
- $249.00M
- Beta
- 1.84
- P/E (TTM)
- 547.5
- EPS (TTM)
- $0.02
Volume 2.57M
Average 0.70M
RMAX Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
RE/MAX Holdings, Inc.NYSE: RMAX
Research & Development · Q1 FY2026 · quarter ended Mar 2026
Research & development remains negative
Q1 FY2026 research & development was $0, compared with $0 a year earlier. Trailing-twelve-month research & development was $0.
Context
- Research & development amounted to 0.0% of revenue in FY2025, unchanged from a year earlier.
- Research & development increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly research & development holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
| FY2021 | 2021-12-31 | 0 | — |
Research & Development vs competitors
How RMAX compares with its peers on the latest reported figures
- RMAX's LTM Mar 2026 research & development of $0 is the 2nd highest of the 9 companies compared; the peer median is $0.
- Research & development amounts to 0.0% of revenue for RMAX, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $11.11M | -48.3% | +20.6% | 1027.5% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| LTM Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding RMAX) | $0 | -48.3% | +20.6% | 0.0% | |
Competitors are the stored peer set for RMAX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 329.7M | 353.39M | 325.67M | 307.69M | 291.6M |
| Cost of Revenue | 82.39M | 90.32M | 83.86M | 78.98M | 123.53M |
| Gross Profit | 247.31M | 263.07M | 241.81M | 228.7M | 168.07M |
| Gross Margin | 75.0% | 74.4% | 74.2% | 74.3% | 57.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 179.49M | 173.98M | 171.55M | 152.26M | 146.7M |
| Operating Expenses | 257.24M | 224.86M | 252.45M | 188.52M | 122.57M |
| Depreciation & Amortization | 31.33M | 35.77M | 32.41M | 29.56M | 25.85M |
| EBITDA | 20.52M | 74.8M | 26.62M | 72.02M | 77.18M |
| EBITDA Margin | 6.2% | 21.2% | 8.2% | 23.4% | 26.5% |
| Operating Income | (9.93M) | 38.21M | (10.64M) | 40.18M | 45.5M |
| Operating Margin | -3.0% | 10.8% | -3.3% | 13.1% | 15.6% |
| Interest Income | 217K | 1.46M | 4.42M | 3.74M | 3.58M |
| Interest Expense | 11.34M | 20.9M | 35.74M | 36.26M | 31.7M |
| Other Income / Expenses | (12.23M) | (20.08M) | (30.9M) | (33.98M) | (25.87M) |
| Income Before Tax | (22.16M) | 18.13M | (41.54M) | 6.2M | 19.63M |
| Pre-Tax Margin | -6.7% | 5.1% | -12.8% | 2.0% | 6.7% |
| Income Tax Expense | 2.46M | 7.37M | 56.95M | (1.88M) | 6.2M |
| Net Income | (15.62M) | 6.11M | (69.02M) | 7.12M | 8.15M |
| Net Margin | -4.7% | 1.7% | -21.2% | 2.3% | 2.8% |
| EPS (Basic) | (0.84) | 0.33 | (3.81) | 0.38 | 0.41 |
| EPS (Diluted) | (0.84) | 0.32 | (3.81) | 0.37 | 0.40 |
| Weighted Avg Shares | 18.69M | 18.68M | 18.11M | 18.78M | 19.85M |
| Weighted Avg Shares (Diluted) | 18.69M | 18.84M | 18.11M | 19.29M | 20.4M |
RE/MAX Holdings, Inc.
NYSE:RMAX
Intrinsic Alpha fair value
Locked
Current Price
$12.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.